Temozolomide during and after Radiotherapy for Newly Diagnosed Glioblastomas : A Prospective Multicenter Study of Korean Patients.
about
Validation of the Effectiveness and Safety of Temozolomide during and after Radiotherapy for Newly Diagnosed Glioblastomas: 10-year Experience of a Single Institution.Pseudoprogression and pseudoresponse in the management of high-grade glioma : optimal decision timing according to the response assessment of the neuro-oncology working group.Concurrent Chemoradiotherapy with Temozolomide Followed by Adjuvant Temozolomide for Newly Diagnosed Glioblastoma Patients: A Retrospective Multicenter Observation Study in Korea.Current evidence of temozolomide and bevacizumab in treatment of gliomas.
P2860
Temozolomide during and after Radiotherapy for Newly Diagnosed Glioblastomas : A Prospective Multicenter Study of Korean Patients.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Temozolomide during and after ...... nter Study of Korean Patients.
@ast
Temozolomide during and after ...... nter Study of Korean Patients.
@en
type
label
Temozolomide during and after ...... nter Study of Korean Patients.
@ast
Temozolomide during and after ...... nter Study of Korean Patients.
@en
prefLabel
Temozolomide during and after ...... nter Study of Korean Patients.
@ast
Temozolomide during and after ...... nter Study of Korean Patients.
@en
P2093
P2860
P1476
Temozolomide during and after ...... nter Study of Korean Patients.
@en
P2093
Chae-Yong Kim
Jeong Hoon Kim
Jin-Deok Joo
Jong Hee Chang
Yong-Kil Hong
Young-Hoon Kim
P2860
P356
10.3340/JKNS.2012.52.2.92
P577
2012-08-31T00:00:00Z